Abstract:BackgroundSmith-Magenis syndrome (SMS) is a developmental disability/multiple congenital anomaly disorder resulting from haploinsufficiency of RAI1. It is characterized by distinctive facial features, brachydactyly, sleep disturbances, and stereotypic behaviors.MethodsWe investigated a cohort of 15 individuals with a clinical suspicion of SMS who showed neither deletion in the SMS critical region nor damaging variants in RAI1 using whole exome sequencing. A combination of network analysis (co-expression and biomedical text mining), transcriptomics, and circularized chromatin conformation capture (4C-seq) was applied to verify whether modified genes are part of the same disease network as known SMS-causing genes.ResultsPotentially deleterious variants were identified in nine of these individuals using whole-exome sequencing. Eight of these changes affect KMT2D, ZEB2, MAP2K2, GLDC, CASK, MECP2, KDM5C, and POGZ, known to be associated with Kabuki syndrome 1, Mowat-Wilson syndrome, cardiofaciocutaneous syndrome, glycine encephalopathy, mental retardation and microcephaly with pontine and cerebellar hypoplasia, X-linked mental retardation 13, X-linked mental retardation Claes-Jensen type, and White-Sutton syndrome, respectively. The ninth individual carries a de novo variant in JAKMIP1, a regulator of neuronal translation that was recently found deleted in a patient with autism spectrum disorder. Analyses of co-expression and biomedical text mining suggest that these pathologies and SMS are part of the same disease network. Further support for this hypothesis was obtained from transcriptome profiling that showed that the expression levels of both Zeb2 and Map2k2 are perturbed in Rai1–/– mice. As an orthogonal approach to potentially contributory disease gene variants, we used chromatin conformation capture to reveal chromatin contacts between RAI1 and the loci flanking ZEB2 and GLDC, as well as between RAI1 and human orthologs of the genes that show perturbed expression in our Rai1–/– mouse model.ConclusionsThese holistic studies of RAI1 and its interactions allow insights into SMS and other disorders associated with intellectual disability and behavioral abnormalities. Our findings support a pan-genomic approach to the molecular diagnosis of a distinctive disorder.

Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics

Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome

Identification by Whole Genome Sequencing and Joint Analysis

Overlapping hearing and communication profiles for the deletion and the RAI1 variant form of Smith-Magenis Syndrome (SMS)

Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome

Evidence for a Potential Common Gene Network of Smith-Magenis and Potocki-Lupski Syndromes, DAND (DEAF1-Associated Neurodevelopmental Disorder) and ZEB1-Associated Neurodevelopment Disorder

Evidence for a Potential Common Gene Network of Smith-Magenis&nbsp;and Potocki-Lupski Syndromes,&nbsp;DAND (DEAF1-Associated Neurodevelopmental Disorder)&nbsp;and&nbsp;ZEB1-Associated Neurodevelopment Disorder

Early Adolescent Rai1 Reactivation Reverses Transcriptional and Social Interaction Deficits in a Mouse Model of Smith–Magenis Syndrome

Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith-Magenis syndrome

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Comparative analyses of the Smith−Magenis syndrome protein RAI1 in mice and common marmoset monkeys

Temporal Dissection of Rai1 Function Reveals Brain-Derived Neurotrophic Factor As a Potential Therapeutic Target for Smith-Magenis Syndrome.

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities

Microdeletion on 17p11.2 in a Smith-Magenis Syndrome Patient with Mental Retardation and Congenital Heart Defect: First Report from China.

Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature

Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes

ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations

Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections